Migraines are a type of severe headache that can have a major impact on everyday life. Migraine symptoms can include visual disturbances such as flashing lights and blind spots in addition to nausea, vomiting, light and sound sensitivity..
Injectable therapy (anti-wrinkle muscle relaxant with ultrafine needles) may be indicated for select patients with chronic migraine, who have not responded to at least 3 migraine preventative agents. A clinical consultation is required to determine if your migraines are likely to respond. Following consultation, and if eligible, you will be given detailed information about the procedure and any potential side effects.
For chronic migraine patients, to confirm eligibility a headache diary (for at least one month) requires completion prior to your appointment. After your first treatment, a headache diary will need to be maintained to ensure ongoing eligibility for PBS funding. It is important to learn to identify the signs and triggers of your migraine to help prevent them. The easiest way of doing this is by keeping a diary about your migraines.
Migraine patients will need to continue regular review with their primary treating GP or neurologist, for migraine treatment in addition to the injection therapy.
It is estimated that about 50-80% of the population have a headache at some time in their life. At any one time headaches affect about 20-50% of the population. An Age newspaper survey recently revealed that 19% of the population suffer from regular headaches, most of these having been diagnosed as migraine-type headaches.
Associate Professor Lynette KiersNeurologist and Clinical Neurophysiologist
MBBS(Hons), FRACP, American Board of Electrodiagnostic medicine
Lynette Kiers is a consultant neurologist and the Director of Clinical Neurophysiology at the Royal Melbourne Hospital. After completing her medical degree and neurology training at the University of Melbourne and Royal Melbourne Hospital, Lyn embarked upon postgraduate training and research in neurophysiology at the Mayo Clinic and Massachusetts General Hospital, USA. Lyn is one of two neurologists managing the bolinum toxin clinic at RMH for the treatment of neurologic disorders. In addition to expertise in clinical neurophysiology for diagnosis of peripheral nerve pathology, she has over 10 years’ experience with botulinum toxin injections for a range of neurologic diseases including hemifacial spasm, blepharospasm, cervical dystonia, dystonic tremor, spasticity, axillary hyperhydrosis and chronic migraine. Lyn consults at Brighton Spinal Group on a Wednesday afternoon. Treatment for the above conditions is funded under the pharmaceutical benefits scheme for patients meeting specific criteria. For further information, please contact our reception team on 9596 7211.